Diageo plc vs Kenvue Inc. Common Stock — how do they compare? Diageo plc trades at $86.5 (market cap $47.67B), while Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B). The key difference: Diageo plc is the larger of the two by market cap, and Kenvue Inc. Common Stock pays the higher dividend (4.74%). Which is the better fit depends on your goals.
| DEO | KVUE | |
|---|---|---|
Market Cap | $47.67B | $34.06B |
Volume | 893,372 | 23,267,228 |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $102.14 | $19.83 |
52-Week Low | $72.47 | $14.11 |
Typical Hold Time | 66 Days | — |
Enterprise Value | $68.09B | $41.56B |
Dividend Yield | 2.3% | 4.74% |
Signals from Pluang's Aura AI — not financial advice
Diageo (DEO) trades at $86.82, up 2.47% with bullish technical signals and strong analyst support. The stock shows solid fundamentals with consistent earnings beats, a 15.82% ROE, and improving cash flow trends. Recent corporate developments include a new CFO appointment and marketing initiatives supporting brand strength amid ongoing US business restructuring.
The outlook remains positive with 49% analyst buy ratings and cost-saving initiatives driving margin improvement. Key risks include US market volatility and regulatory challenges in India. The stock presents a compelling turnaround story with valuation support at current levels.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →